Prostate cancer

Reducing overtreatment: Active surveillance in low-risk disease

Jared M Whitson, Sima P. Porten, Peter R. Carroll

Research output: Contribution to journal › Short survey

4 Citations (Scopus)

Abstract

Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.

Original languageEnglish (US)
Pages (from-to)124-125
Number of pages2
JournalNature Reviews Urology
Volume8
Issue number3
DOIs
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Neoplasms
Early Detection of Cancer
Morbidity
Mortality
Medical Overuse

ASJC Scopus subject areas

  • Urology

Cite this

Prostate cancer : Reducing overtreatment: Active surveillance in low-risk disease. / Whitson, Jared M; Porten, Sima P.; Carroll, Peter R.

In: Nature Reviews Urology, Vol. 8, No. 3, 04.2011, p. 124-125.

Research output: Contribution to journal › Short survey

Whitson, JM, Porten, SP & Carroll, PR 2011, 'Prostate cancer: Reducing overtreatment: Active surveillance in low-risk disease', Nature Reviews Urology, vol. 8, no. 3, pp. 124-125. https://doi.org/10.1038/nrurol.2011.8
Whitson JM, Porten SP, Carroll PR. Prostate cancer: Reducing overtreatment: Active surveillance in low-risk disease. Nature Reviews Urology. 2011 Apr;8(3):124-125. https://doi.org/10.1038/nrurol.2011.8
Whitson, Jared M ; Porten, Sima P. ; Carroll, Peter R. / Prostate cancer : Reducing overtreatment: Active surveillance in low-risk disease. In: Nature Reviews Urology. 2011 ; Vol. 8, No. 3. pp. 124-125.
@article{df21ed121d9941e19e75fba4343e3cc4,
title = "Prostate cancer: Reducing overtreatment: Active surveillance in low-risk disease",
abstract = "Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.",
author = "Whitson, {Jared M} and Porten, {Sima P.} and Carroll, {Peter R.}",
year = "2011",
month = "4",
doi = "10.1038/nrurol.2011.8",
language = "English (US)",
volume = "8",
pages = "124--125",
journal = "Nature Reviews Urology",
issn = "1759-4812",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Prostate cancer

T2 - Reducing overtreatment: Active surveillance in low-risk disease

AU - Whitson, Jared M

AU - Porten, Sima P.

AU - Carroll, Peter R.

PY - 2011/4

Y1 - 2011/4

N2 - Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.

AB - Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.

UR - http://www.scopus.com/inward/record.url?scp=79952705000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952705000&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2011.8

DO - 10.1038/nrurol.2011.8

M3 - Short survey

VL - 8

SP - 124

EP - 125

JO - Nature Reviews Urology

JF - Nature Reviews Urology

SN - 1759-4812

IS - 3

ER -

Access to Document